Law firm seeks lead plaintiffs in Replimune securities fraud suit

By Atlas Watchline Staff · Legal · August 25, 2026

A law firm says investors who lost money in Replimune Group, Inc. shares may seek to lead a securities fraud class action over alleged misleading disclosures.

A law firm says investors who lost money in Replimune Group, Inc. shares may seek to lead a securities fraud class action over alleged misleading disclosures.

LOS ANGELES — The Law Offices of Frank R. Cruz said in a PR Newswire release dated Aug. 25, 2026, that investors with losses in Replimune Group, Inc. (REPL) may seek to lead an ongoing securities fraud class action lawsuit.

The release says the lead plaintiff deadline is Oct. 5, 2026. It describes allegations in a proposed class-action complaint covering Oct. 20, 2025, through Apr. 10, 2026.

The law-firm release says the complaint alleges defendants made materially false or misleading statements and failed to disclose adverse facts about the company’s business, operations and prospects. Among the alleged omissions, the release says, were FDA study design concerns related to the BLA that were not addressed and data from an early unplanned analysis from RP1-104 that included 40 patients, which the release says was 10% of planned enrollment of 400 patients.

The release also says RPL-001-16 and RP1-104 had deficiencies that were likely to cause the FDA to reject the BLA. It further alleges that positive statements about the company’s business, operations and prospects lacked a reasonable basis.

The source is a law-firm solicitation rather than an adjudicated court filing or company statement. The release says potential class members do not need to act now and may retain counsel of their choice or remain absent members of the class action.

It also provides contact information for the firm and says the notice may be considered attorney advertising in some jurisdictions.

What happens next depends on the securities case process and the Oct. 5 lead plaintiff deadline named in the release.

Sources

• PR Newswire release from The Law Offices of Frank R. Cruz

Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.

This is the AMP version of the article. Read the full article on Atlas Watchline.